MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

NCT06198868 · clinicaltrials.gov ↗

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

PROCEDURE: Operable

Sponsor

Jiangsu Cancer Institute & Hospital